Clinical Trials Logo

Bilateral Blepharospasm (BEB) clinical trials

View clinical trials related to Bilateral Blepharospasm (BEB).

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01896895 Completed - Clinical trials for Bilateral Blepharospasm (BEB)

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid

Start date: November 2013
Phase: Phase 3
Study type: Interventional

This phase 3 study will serve to collect efficacy and safety data of two different doses of NT 201 in subjects suffering from Bilateral Blepharospasm (BEB) who are BTX treatment-naïve. In this study, BTX treatment-naïve subjects are defined as those who have not received BTX treatment within the last 12 months for the treatment of BEB. This definition aims to avoid bias by comparison of treatment effects in the subject's assessments. Furthermore, this study will substantiate the existing efficacy and safety database for the indication BEB.